The Journal of Immunology, Vol 155, Issue 4 1829-1837, Copyright © 1995 by American Association of Immunologists

ARTICLES

CD28-mediated signaling in vivo prevents activation-induced apoptosis in the thymus and alters peripheral lymphocyte homeostasis

Y Shi, LG Radvanyi, A Sharma, P Shaw, DR Green, RG Miller and GB Mills
Toronto Hospital, Canada.

Activation of T lymphocytes can result in a functional immune response, anergy or apoptosis. Functional T cell activation requires the interaction of the TCR with Ag presented by MHC molecules on APC concurrent with appropriate interactions between cell surface accessory molecules. Interestingly, the level of CD28 expression is regulated during T cell development as well as during T cell activation and proliferation, suggesting that CD28 could play a role in determining the outcome of activation of TCR during T cell ontogeny. We identify, herein, a novel function of murine CD28 in the regulation of activation- induced apoptosis in thymocytes. In vivo, or combined in vivo and in vitro treatment with mAbs to CD28 prevents apoptosis of CD4+CD8+ thymocytes induced by Abs to the TCR complex. Prolonged administration of anti-CD28 Abs increased the number of both CD4+CD8- and CD4-CD8+ T cells in the thymus, while the number of CD4+CD8+ T cells is relatively unchanged. Furthermore, this treatment leads to a dramatic enlargement of peripheral lymphoid organs characterized primarily by the expansion of B cells. The number of CD4+CD8- T cells in the spleen of anti-CD28- treated mice is also moderately increased, while the number of CD4-CD8+ cells is relatively unchanged.

This article has been cited by other articles:

				D. Friedmann-Morvinski, A. Bendavid, T. Waks, D. Schindler, and Z. Eshhar Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation Blood, April 15, 2005; 105(8): 3087 - 3093. [Abstract] [Full Text] [PDF]

				M Bijl, G Horst, P C Limburg, and C G M Kallenberg Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus Ann Rheum Dis, May 1, 2001; 60(5): 523 - 526. [Abstract] [Full Text] [PDF]

				K. Saegusa, N. Ishimaru, K. Yanagi, N. Haneji, M. Nishino, M. Azuma, I. Saito, and Y. Hayashi Autoantigen-Specific CD4+CD28low T Cell Subset Prevents Autoimmune Exocrinopathy in Murine Sjogren's Syndrome J. Immunol., August 15, 2000; 165(4): 2251 - 2257. [Abstract] [Full Text] [PDF]

				N. J. Borthwick, M. Lowdell, M. Salmon, and A. N. Akbar Loss of CD28 expression on CD8+ T cells is induced by IL-2 receptor {gamma} chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis Int. Immunol., July 1, 2000; 12(7): 1005 - 1013. [Abstract] [Full Text] [PDF]

				X.-Z. Yu, S. J. Bidwell, P. J. Martin, and C. Anasetti CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice J. Immunol., May 1, 2000; 164(9): 4564 - 4568. [Abstract] [Full Text] [PDF]

				D. Yin, L. Zhang, R. Wang, L. Radvanyi, C. Haudenschild, Q. Fang, M. R. Kehry, and Y. Shi Ligation of CD28 In Vivo Induces CD40 Ligand Expression and Promotes B Cell Survival J. Immunol., October 15, 1999; 163(8): 4328 - 4334. [Abstract] [Full Text] [PDF]

				A. Sadra, T. Cinek, J. L. Arellano, J. Shi, K. E. Truitt, and J. B. Imboden Identification of Tyrosine Phosphorylation Sites in the CD28 Cytoplasmic Domain and Their Role in the Costimulation of Jurkat T Cells J. Immunol., February 15, 1999; 162(4): 1966 - 1973. [Abstract] [Full Text] [PDF]

				N. Dautigny, A. Le Campion, and B. Lucas Timing and Casting for Actors of Thymic Negative Selection J. Immunol., February 1, 1999; 162(3): 1294 - 1302. [Abstract] [Full Text] [PDF]

				S. A. HUBER, R. C. BUDD, K. ROSSNER, and M. K. NEWELL Apoptosis in Coxsackievirus B3-induced Myocarditis and Dilated Cardiomyopathy Ann. N.Y. Acad. Sci., January 1, 1999; 887(1): 181 - 190. [Abstract] [Full Text] [PDF]

				Y. Lu, B. Cuevas, S. Gibson, H. Khan, R. LaPushin, J. Imboden, and G. B. Mills Phosphatidylinositol 3-Kinase Is Required for CD28 But Not CD3 Regulation of the TEC Family Tyrosine Kinase EMT/ITK/TSK: Functional and Physical Interaction of EMT with Phosphatidylinositol 3-Kinase J. Immunol., November 15, 1998; 161(10): 5404 - 5412. [Abstract] [Full Text] [PDF]

				P. S. Hinton, C. A. Peterson, E. M. Dahly, and D. M. Ney IGF-I alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R912 - R920. [Abstract] [Full Text] [PDF]

				Y. V Bobryshev and R. S.A Lord Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions Cardiovasc Res, March 1, 1998; 37(3): 799 - 810. [Abstract] [Full Text] [PDF]

				C. A. Chambers, D. Cado, T. Truong, and J. P. Allison Thymocyte development is normal in CTLA-4-deficient mice PNAS, August 19, 1997; 94(17): 9296 - 9301. [Abstract] [Full Text] [PDF]

				G. G. Bashian, C. M. Braun, S.-K. Huang, A. Kagey-Sobotka, L. M. Lichtenstein, and D. M. Essayan Differential Regulation of Human, Antigen-specific Th1 and Th2 Responses by the B-7 Homologues, CD80 and CD86 Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 235 - 242. [Abstract] [Full Text]

				S. Gibson, A. August, D. Branch, B. Dupont, and G. B. Mills Functional LCK Is Required for Optimal CD28-mediated Activation of the TEC Family Tyrosine Kinase EMT/ITK J. Biol. Chem., March 22, 1996; 271(12): 7079 - 7083. [Abstract] [Full Text] [PDF]